Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.
Fabbri A, Nelli F, Botticelli A, Giannarelli D, Marrucci E, Fiore C, Virtuoso A, Scagnoli S, Pisegna S, Alesini D, Sini V, Orlandi A, Fabi A, Piacentini F, Moscetti L, D'Auria G, Gamucci T, Mazzotta M, Pizzuti L, Vici P, Cretella E, Scavina P, La Cesa A, Persano M, Atzori F, Ruggeri EM. Fabbri A, et al. Among authors: nelli f. Front Oncol. 2023 Jun 27;13:1177681. doi: 10.3389/fonc.2023.1177681. eCollection 2023. Front Oncol. 2023. PMID: 37441419 Free PMC article.
EGFR inhibitors: clinical results.
De Marinis F, Nelli F, D'Auria G. De Marinis F, et al. Among authors: nelli f. Suppl Tumori. 2002 Nov-Dec;1(6):S5-6. doi: 10.1177/03008916020016s102. Suppl Tumori. 2002. PMID: 12658893 Review. No abstract available.
Induction therapy with paclitaxel and carboplatin followed by hyperfractionated radiotherapy plus weekly concurrent chemotherapy and subsequent consolidation therapy in unresectable locally advanced non-small-cell lung cancer.
Cortesi E, Moscetti L, Nelli F, De Marinis F, De Paula U, Bangrazi C, Migliorino MR, Donato V. Cortesi E, et al. Among authors: nelli f. Tumori. 2007 Mar-Apr;93(2):133-7. doi: 10.1177/030089160709300204. Tumori. 2007. PMID: 17557558 Clinical Trial.
Rhabdomyolysis from erlotinib: a case report.
Moscetti L, Nelli F, Ruggeri EM. Moscetti L, et al. Among authors: nelli f. Tumori. 2011 May-Jun;97(3):415-6. doi: 10.1177/030089161109700327. Tumori. 2011. PMID: 21789026 No abstract available.
76 results